Stay updated on Rucaparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Locations section was expanded and reorganized to include numerous regional sites across the US, Canada, Australia, and Europe. Some locations were added (e.g., Arizona, California, New South Wales, Île-de-France) and others removed, in the v3.3.3 revision.SummaryDifference2%

- Check52 days agoChange DetectedA PubMed-based note about publications being automatically filled (and may not all pertain to the study) has been added, and the Revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.4%

- Check59 days agoChange DetectedThe page removes a government funding/operating-status notice that was previously shown; core study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedNo significant changes to the Study Details page content were detected between versions. Core information such as the study title, NCT number, design, eligibility criteria, primary outcomes, and locations remains the same.SummaryDifference0.2%

- Check102 days agoChange DetectedUpdated location region from Rhone-Alpes to Auvergne-Rhône-Alpes with new city entries, and bumped revision to v3.2.0; removed the old Rhone-Alpes entries and old revision v3.1.0. Added a government operating-status notice.SummaryDifference5%

Stay in the know with updates to Rucaparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.